Oramed Pharmaceuticals
ORMP
#9229
Rank
$0.16 B
Marketcap
$3.97
Share price
-0.75%
Change (1 day)
74.12%
Change (1 year)

Oramed Pharmaceuticals (ORMP) Fails to deliver data

Key failure to deliver metrics for Oramed Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Oramed Pharmaceuticals (ORMP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Oramed Pharmaceuticals (ORMP) - since 2013

Volume in USD (price x number of shares), data since 2013

Oramed Pharmaceuticals (ORMP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024$0.14 M-97.18%
2023$5.23 M-82.2%
2022$29.42 M15.91%
2021$25.38 M418.21%
2020$4.89 M429.07%
2019$0.92 M29.09%
2018$0.71 M-73.46%
2017$2.7 M-85.35%
2016$18.44 M118.71%
2015$8.43 M-34.36%
2014$12.85 M166.85%
2013$4.81 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novo Nordisk
NVO
$64.24 M$0.45 B๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
$19.95 M$38.55 M๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
$4.45 M$13.69 M๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
$1.06 M$3.45 M๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
$0.25 M$1.48 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel